|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-18
|
|
pubmed:abstractText |
Atazanavir seems to be a protease inhibitor (PI) with a more favourable metabolic profile. Information regarding the potential benefit of replacing lopinavir/ritonavir by atazanavir in HIV-infected patients with prolonged viral suppression is scarce. If proved, this strategy could be particularly attractive for the subset of patients with greater cardiovascular risk.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1460-2091
|
|
pubmed:author |
pubmed-author:BarreiroPabloP,
pubmed-author:BlancoFranciscoF,
pubmed-author:García-GascoPilarP,
pubmed-author:González-LahozJuanJ,
pubmed-author:Martín-CarboneroLuzL,
pubmed-author:MorelloJuditJ,
pubmed-author:RivasPabloP,
pubmed-author:Rodríguez-NovoaSoniaS,
pubmed-author:Ruiz-SanchoAndrésA,
pubmed-author:SorianoVincentV,
pubmed-author:VispoEugeniaE,
pubmed-author:de MendozaCarmenC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
200-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17999977-Adult,
pubmed-meshheading:17999977-Aged,
pubmed-meshheading:17999977-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:17999977-Blood Glucose,
pubmed-meshheading:17999977-CD4 Lymphocyte Count,
pubmed-meshheading:17999977-Drug Administration Schedule,
pubmed-meshheading:17999977-Female,
pubmed-meshheading:17999977-Follow-Up Studies,
pubmed-meshheading:17999977-HIV Infections,
pubmed-meshheading:17999977-HIV Protease Inhibitors,
pubmed-meshheading:17999977-HIV-1,
pubmed-meshheading:17999977-Humans,
pubmed-meshheading:17999977-Lipids,
pubmed-meshheading:17999977-Lopinavir,
pubmed-meshheading:17999977-Male,
pubmed-meshheading:17999977-Middle Aged,
pubmed-meshheading:17999977-Oligopeptides,
pubmed-meshheading:17999977-Prospective Studies,
pubmed-meshheading:17999977-Pyridines,
pubmed-meshheading:17999977-Pyrimidinones,
pubmed-meshheading:17999977-RNA, Viral,
pubmed-meshheading:17999977-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain. vsoriano@dragonet.es
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
